The store will not work correctly when cookies are disabled.
3-(4'-hydroxy-2'-cyclopenten-10-yl)-1,3-diaza-2-oxophenoxazine
ID: ALA4873788
PubChem CID: 164624403
Max Phase: Preclinical
Molecular Formula: C15H13N3O3
Molecular Weight: 283.29
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=c1nc2c(cn1[C@H]1C=C[C@@H](O)C1)Oc1ccccc1N2
Standard InChI: InChI=1S/C15H13N3O3/c19-10-6-5-9(7-10)18-8-13-14(17-15(18)20)16-11-3-1-2-4-12(11)21-13/h1-6,8-10,19H,7H2,(H,16,17,20)/t9-,10+/m0/s1
Standard InChI Key: XALXOSMGSTXHRZ-VHSXEESVSA-N
Molfile:
RDKit 2D
21 24 0 0 0 0 0 0 0 0999 V2000
6.0042 -26.0759 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0031 -26.9030 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4309 -26.0723 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7158 -25.6634 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4337 -26.9025 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7163 -27.3167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7164 -28.1406 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.1512 -27.3121 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.1495 -28.1421 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4315 -28.5594 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4338 -29.3852 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1525 -29.8002 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.8706 -29.3829 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8699 -28.5508 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.1537 -30.6248 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4868 -31.1118 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7428 -31.8957 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5675 -31.8945 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8210 -31.1099 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2590 -32.5635 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.5854 -29.7939 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 6 1 0
5 3 1 0
3 4 2 0
4 1 1 0
5 6 2 0
5 8 1 0
6 7 1 0
7 10 1 0
9 8 1 0
9 10 1 0
9 14 2 0
10 11 2 0
11 12 1 0
12 13 1 0
13 14 1 0
15 12 1 1
15 16 1 0
16 17 1 0
17 18 1 0
18 19 2 0
19 15 1 0
17 20 1 1
13 21 2 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 283.29 | Molecular Weight (Monoisotopic): 283.0957 | AlogP: 1.95 | #Rotatable Bonds: 1 |
Polar Surface Area: 76.38 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 0.60 | CX LogD: 0.60 |
Aromatic Rings: 2 | Heavy Atoms: 21 | QED Weighted: 0.67 | Np Likeness Score: 0.49 |
References
1. Kozlovskaya LI, Volok VP, Shtro AA, Nikolaeva YV, Chistov AA, Matyugina ES, Belyaev ES, Jegorov AV, Snoeck R, Korshun VA, Andrei G, Osolodkin DI, Ishmukhametov AA, Aralov AV.. (2021) Phenoxazine nucleoside derivatives with a multiple activity against RNA and DNA viruses., 220 [PMID:33894564] [10.1016/j.ejmech.2021.113467] |